APA (7th ed.) Citation

Rabbani, A., Alaei, M., Asl, S. N., Setoodeh, A., Shakiba, M., Salehpour, S., . . . Jarollahi, A. (2025). Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-16351-4

Chicago Style (17th ed.) Citation

Rabbani, Ali, et al. "Efficacy and Safety of a Biosimilar Laronidase Versus the Reference Laronidase in Patients with Mucopolysaccharidosis Type I." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-16351-4.

MLA (9th ed.) Citation

Rabbani, Ali, et al. "Efficacy and Safety of a Biosimilar Laronidase Versus the Reference Laronidase in Patients with Mucopolysaccharidosis Type I." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-16351-4.